These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 32036540)

  • 1. Approaches to optimize therapeutic bacteriophage and bacteriophage-derived products to combat bacterial infections.
    Reuter M; Kruger DH
    Virus Genes; 2020 Apr; 56(2):136-149. PubMed ID: 32036540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophages as Therapeutic Preparations: What Restricts Their Application in Medicine.
    Vlassov VV; Tikunova NV; Morozova VV
    Biochemistry (Mosc); 2020 Nov; 85(11):1350-1361. PubMed ID: 33280578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotechnological applications of bacteriophages: State of the art.
    Harada LK; Silva EC; Campos WF; Del Fiol FS; Vila M; Dąbrowska K; Krylov VN; Balcão VM
    Microbiol Res; 2018; 212-213():38-58. PubMed ID: 29853167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combatting intracellular pathogens using bacteriophage delivery.
    Goswami A; Sharma PR; Agarwal R
    Crit Rev Microbiol; 2021 Aug; 47(4):461-478. PubMed ID: 33818246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
    Kulshrestha M; Tiwari M; Tiwari V
    Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Back to the future: bacteriophages as promising therapeutic tools.
    Domingo-Calap P; Georgel P; Bahram S
    HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.
    Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY
    J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.
    Mangalea MR; Duerkop BA
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32094257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?
    Maciejewska B; Olszak T; Drulis-Kawa Z
    Appl Microbiol Biotechnol; 2018 Mar; 102(6):2563-2581. PubMed ID: 29442169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
    Kakasis A; Panitsa G
    Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phages amid antimicrobial resistance.
    Mohan Raj JR; Karunasagar I
    Crit Rev Microbiol; 2019; 45(5-6):701-711. PubMed ID: 31775552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A commentary on the development of engineered phage as therapeutics.
    Barnard AML; Fairhead HIM
    Drug Discov Today; 2021 Sep; 26(9):2095-2098. PubMed ID: 34237459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage Infections of Biofilms of Health Care-Associated Pathogens:
    Santiago AJ; Donlan RM
    EcoSal Plus; 2020 Oct; 9(1):. PubMed ID: 33118486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Machinery of the Triad Holin, Endolysin, and Spanin: Key Players Orchestrating Bacteriophage-Induced Cell Lysis and their Therapeutic Applications.
    Samir S
    Protein Pept Lett; 2024; 31(2):85-96. PubMed ID: 38258777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Characteristics of Phages to Guide 'Real Life' Phage Therapy Suitability.
    Casey E; van Sinderen D; Mahony J
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29601536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophage therapy: recent developments and applications of a renaissant weapon.
    Fathima B; Archer AC
    Res Microbiol; 2021; 172(6):103863. PubMed ID: 34293451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.